1270.3000 -21.80 (-1.69%)
NSE Jul 31, 2025 15:31 PM
Volume: 2.0M
 

1270.30
-1.69%
SMC online
Other operating income at Rs.380 crore; includes Rs.350 crore received from Celgene pursuant to an agreement entered towards settlement of any claim the Company or its affiliates may have had for damages under section 8 of the Canadian Patented Medicines (Notice of Compliance) Regulations in regard to the Company's ANDS for a generic version of...
Dr. Reddy's Laboratories Ltd. is trading above its 200 day SMA of 1243.7
More from Dr. Reddy's Laboratories Ltd.
Recommended